Defatted Powder Of Arachis Hypogaea L., Semen (Peanuts)
drugOn this page
Also known as DBV-712PalforziaPeanut proteinPeanut protein flour
Summary
Defatted Powder Of Arachis Hypogaea L., Semen (Peanuts) (CHEMBL5315089) is an approved unknown; indicated across 1 condition.
At a glance
- Status: Approved (max clinical phase 4)
- Modality: Unknown
- Indications: 1 condition
- Clinical trials: 5
Identifiers
Drug identity and classification
| Field | Value |
|---|---|
| ChEMBL ID | CHEMBL5315089 |
| Name | Defatted Powder Of Arachis Hypogaea L., Semen (Peanuts) |
| Type | Unknown |
| Max phase | 4 |
Also known as: DBV-712, Palforzia, Peanut protein, Peanut protein flour
Targets
Targets
No target linkage available.
Bioactivity
No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).
Target pathways
No target-pathway data for this drug (no mapped target genes).
Indications & clinical
Indications
1 indication (1 at ChEMBL trial phase 4).
The 1 indication record carries no mapped disease name (EFO/MeSH-only); none shown.
Clinical trials
Total trials: 5.
Phase distribution
| Phase | Trials |
|---|---|
| PHASE2 | 3 |
| EARLY_PHASE1 | 1 |
| Not specified | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT01601522 | PHASE2 | COMPLETED | Peanut Allergy Oral Immunotherapy Desensitization |
| NCT02103270 | PHASE2 | COMPLETED | The Peanut Oral Immunotherapy Study: Safety, Efficacy and Discovery |
| NCT03907397 | PHASE2 | COMPLETED | Immune Basis and Clinical Implications of Threshold-based Phenotypes of Peanut Allergy |
| NCT01891136 | EARLY_PHASE1 | COMPLETED | Oral Peanut Immunotherapy for Peanut Allergic Patients |
| NCT06693544 | Not specified | ENROLLING_BY_INVITATION | Peanut Sip Feeding Protocol |
Clinical evidence (CIViC)
No CIViC predictive evidence (expected for non-precision-medicine drugs).
Pharmacology
Pharmacogenomics
No PharmGKB pharmacogenomic data curated for this drug.
Related molecules
Related molecules
No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.